NCT02565732View on ClinicalTrials.gov

Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Hyperhidrosis
Interventions
BIOLOGICAL

Botulinum toxin type A

Botulinum toxin type A, Dose A, Topical

BIOLOGICAL

Botulinum toxin type A

Botulinum toxin type A, Dose B, Topical

BIOLOGICAL

Placebo comparator

Placebo, Dose C, Topical

Trial Locations (1)

94117

San Francisco

All Listed Sponsors
lead

Revance Therapeutics, Inc.

INDUSTRY

NCT02565732 - Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis | Biotech Hunter | Biotech Hunter